Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 39,39 € (+30,43 %). La mediana es de 39,21 € (+29,83 %).
| Comprar |
16 |
| Mantener |
2 |
| Vender |
0 |
Noticias Ir al feed de noticias
Medline warns customers after electric beds linked to fires and two deaths
The FDA warned that Medline electric hospital beds can overheat and catch fire after two deaths and 16 serious injuries were reported. Medline instructed customers to stop using affected beds without modifications, advised vendors to halt sales of beds and related accessories, and recommended fixes for in‑use units. The company said it will end production and exit the homecare and long‑term care bed market. » Más en cbsnews.com
Medline shares plunge in premarket trading after disappointing Q2 results
Medline shares lost 11.4% in premarket trading after the release of disappointing second-quarter 2026 results, intensifying concerns over profitability and cost pressure. The weak Q1 figures—showing declining net income and a compressed margin—set the backdrop, with further pressure from a UBS price-target cut and the resignation of the COO. The stock fell to $37.25, well below the analyst consensus of about $50.92 and closer to its 52-week low than its high. » Más en de.investing.com
Medline to become primary supplier for Allina Health
Medline has signed a primary supplier agreement with Allina Health that gives Allina access to medical‑surgical products and distribution services for its 12 hospitals and more than 90 clinics in Minnesota and western Wisconsin. The agreement is intended to strengthen supply security and to drive standardization of products, processes and data across the health system. Medline thereby expands an existing partnership and will provide supply‑chain solutions for Allina Health’s network. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | junio de 2026 | YoY |
|---|---|---|
| Ingresos | 6745,16 M | 15,46 % |
| Beneficio bruto | 1944,11 M | 32,53 % |
| Beneficio neto | 52,66 M | 81,36 % |
| EBITDA | 578,41 M | 19,03 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 26,59 mil M € |
Número de acciones | 877,35 M |
Máximo/mínimo de 52 semanas | 45,34 € - 27,96 € |
| Dividendos | No |
Beta | -0,39 |
Ratio P/E | 39,54 |
Ratio PEG | -1,31 |
Ratio P/B | 2,52 |
Ratio P/S | 1,00 |
Perfil de la empresa
| Nombre | MEDLINE INC. CL. A O.N. |
| CEO | James Boyle |
| Empleados | 45.000 |